Baird analyst Mark Marcon upgraded HealthEquity to Outperform from Neutral with a price target of $87, up from $79.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on HQY:
- UPDATE: Conduent’s BenefitWallet HSA Portfolio Moving to HealthEquity
- Conduent’s BenefitWallet HSA portfolio moving to HealthEquity
- HealthEquity management to meet virtually with Oppenheimer
- HealthEquity price target raised to $72 from $71 at Deutsche Bank
- HealthEquity price target raised to $85 from $80 at Barrington
Questions or Comments about the article? Write to editor@tipranks.com